Cardiovascular Market Research Reports & Industry Analysis
Variations in heart size and position within the chest may be related to age, body size, shape, weight, or pathologic conditions of the heart and other nearby structures.
There has been considerable study into the role of inflammation in heart disease. Researchers have found the first direct evidence that reducing inflammation in coronary arteries decreases the risk of heart attacks as much as reducing cholesterol levels. This finding offers a new approach to preventing heart disease. Two studies showed that inflammation of the arteries can be reduced by more aggressive use of statins. New drugs that target inflammation that are measured by a marker called Creactive rotein (CRP) could have a large impact on cardiovascular health as well as a large financial gain for companies developing these products.
Cardiovascular Industry Research & Market Reports
-
Global Myocardial Infarction Partnering 2012 to 2018
... partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals and agreements entered into by the ... Read More
-
Global Cardiovascular Partnering 2012-2018: Deal trends, players and financials
... in Cardiovascular partnering deals Financial deal terms for headline, upfront and royalty by stage of development Cardiovascular partnering agreement structure Cardiovascular partnering contract documents Top Cardiovascular deals by value Most active Cardiovascular dealmakers Most of ... Read More
-
Global Angina Partnering 2012-2018
... deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals and agreements entered into by the world’s ... Read More
-
Global Coronary Artery Disease Partnering 2012 to 2018
... Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals and agreements entered into ... Read More
-
Global Arrhythmia Partnering 2012 to 2018
... in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals and agreements entered into by ... Read More
-
Global Stroke Partnering 2012 to 2018
... in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals and agreements entered into by ... Read More
-
Global Congestive Heart Failure Partnering 2012 to 2018
... Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals and agreements entered into ... Read More
-
Global Atherosclerosis Partnering 2012 to 2018
... in partnering deals • Top deals by value • Deals listed by company A-Z, industry sector, stage of development, technology typeThe report provides understanding and access to the partnering deals and agreements entered into by ... Read More
-
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2018
Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peripheral Arterial Disease Peripheral Read More
-
Atherosclerosis - Pipeline Review, H2 2018
Atherosclerosis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis - Pipeline Review, H2 2018, provides an overview of the Atherosclerosis (Car Read More
-
Angina (Angina Pectoris) - Pipeline Review, H2 2018
Angina (Angina Pectoris) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Angina (Angina Pectoris) - Pipeline Review, H2 2018, provides an overview of the An Read More
-
Stroke - Pipeline Review, H2 2018
Stroke - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Pipeline Review, H2 2018, provides an overview of the Stroke (Cardiovascular) pipeline lands Read More
-
Heart Valve Repair and Replacement Devices Market - Global Outlook and Forecast 2018-2023
... growing at an impressive CAGR of around 17% during 2017-2023. The government organizations and leading manufacturers involved in spreading awareness, education, and support about various types of cardiac diseases will have a positive impact on ... Read More
-
Heart Failure Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Rising Geriatric Population and Increasing Uptake of Recently Launched Therapy
... mortality. There are more than 26 million people with HF globally and this is increasing because of the rapidly aging population. HF is a major global healthcare problem as the number of HF patients is ... Read More
-
Dyslipidemia - Pipeline Review, H2 2018
... is defined as elevation of the total cholesterol, the bad low-density lipoprotein (LDL) cholesterol and the triglyceride concentrations, and a decrease in the good high-density lipoprotein (HDL) cholesterol concentration in the blood. Numerous factors and ... Read More
-
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2018
... of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape. Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out ... Read More
-
Myocardial Infarction - Pipeline Review, H2 2018
... landscape. Myocardial infarction is the irreversible necrosis of heart muscle secondary to prolonged ischemia. Symptoms include pain, fullness, and/or squeezing sensation of the chest, jaw pain, toothache, headache, shortness of breath, nausea, vomiting, and/or general ... Read More
-
Atrial Fibrillation - Pipeline Review, H2 2018
... landscape. Atrial fibrillation is an irregular and often rapid heart rate that commonly causes poor blood flow to the body. Symptoms include decreased blood pressure, weakness, light headedness, confusion and chest pain. The predisposing factors ... Read More
-
Global Pulmonary Arterial Hypertension (PAH) Market: Industry Analysis & Outlook (2018-2022)
... as obstructive sleep apnea (OSA), lung diseases, diastolic heart failure and diseases of the left heart can cause the pressures in the pulmonary arteries to elevate but is not pulmonary arterial hypertension. PAH is a ... Read More
-
Cardiologists
Cardiologists Cardiologists Read More
-
Cardiac Biomarkers (Clinical Laboratory testing, Point-of-Care Testing (POCT), etc.)
... report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis ... Read More
-
Structural Heart Devices Global Market – Forecast To 2024
... become older and risk of cardiovascular diseases increase with aging. The cardiovascular diseases which also include structural heart diseases have become leading cause of death. It is projected that, with newfound prosperity due to globalization ... Read More
-
Acute Ischemic Stroke: Epidemiology Forecast to 2027
... approximately 65-90% of stroke cases across the US, Europe, and Asia. The major risk factors associated with the development of Acute Ischemic Stroke (AIS) include both modifiable and non-modifiable conditions, such as hypertension, smoking, diabetes ... Read More
-
Mice Model Market By Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice), Service (Breeding, Rederivation), Therapeutic Area (Oncology, Heart Disease), Technology (CRISPR Cas9, SCNT), Mice Care Product (Cage, Feed)- Global Forecast (2018- 2023)
... To 2023 Mice Model Market by Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice), Service (Breeding, Rederivation), Therapeutic Area (Oncology, Heart Disease), Technology (CRISPR Cas9, SCNT), Mice Care Product (Cage, Feed), and End User- Global ... Read More
-
Biosurgery Market by Product (Fibrin & Collagen Sealant, Hemostats, Adhesion Barriers, Biological Meshs, Soft Tissue Attachments, Stapler, Bone Graft Substitutes) Application (Orthopedic, Gynecology, Cardiovascular, Reconstructive) - Forecast to 2023
... grow at a CAGR of 6.5%.” The biosurgery market is projected to reach USD 15.58 billion by 2023 from estimated USD 11.36 billion in 2018 at a CAGR of 6.5%. Factors such as the growing ... Read More
